Skip to main content
Clinical Trials/ITMCTR2000003860
ITMCTR2000003860
Recruiting
N/A

Study and Application of minimally invasive interventional therapy for thyroid tumor combined with Traditional Chinese medicine

Shanghai Hospital of Traditional Chinese Medicine0 sitesTBD
ConditionsThyroid tumor

Overview

Phase
N/A
Intervention
Not specified
Conditions
Thyroid tumor
Sponsor
Shanghai Hospital of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Shanghai Hospital of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • (1\) It conforms to the western medicine diagnostic standard of thyroid tumor and the Traditional Chinese medicine diagnostic standard of gall disease.
  • (2\) Aged from 18 to 78 (including 18 and 78\).
  • (3\) Benign thyroid nodules or thyroid micropapillary carcinomas may be diagnosed by imaging or needle aspiration cytology or coarse needle aspiration biopsy, and ultrasound may indicate calcification and/or abundant blood flow signals in the nodules.
  • (4\) The external convex of the tubercle affects the aesthetic appearance or has a higher requirement for postoperative aesthetic appearance.
  • (5\) Those who refuse surgical resection and require minimally invasive surgery.
  • (6\) Patients requiring minimally invasive surgery due to excessive anxiety about thyroid tumors.

Exclusion Criteria

  • (1\) Severe damage to vital organs, mental illness, obvious abnormalities in coagulation and thyroid function.
  • (2\) Pregnant.
  • (3\) According to the judgment of the researchers, other medical histories that reduce the possibility of enrollment or complicate enrollment, such as frequent changes in the work environment, may easily lead to loss of follow\-up.
  • (4\) Subjects who are participating in clinical studies of other drugs or have just finished clinical trials of other drugs for less than 3 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials